Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIAP.L Regulatory News (IAP)

  • There is currently no data for IAP

Interim Management Statement

5 Feb 2014 07:00

RNS Number : 3022Z
ICAP PLC
05 February 2014
 



ICAP plc Interim Management Statement

 

· Financial regulatory reform accelerating growth in post trade

· Successful launch of EBS Direct delivering strong volume growth and a wider customer base

· Global Broking continues to be impacted by bank deleveraging

 

London, 5 February 2014 - ICAP plc (IAP.L), a leading markets operator and provider of post trade risk mitigation and information services, issues the following Interim Management Statement for the period from 1 October 2013 to 4 February 2014.

During the period, ICAP continued to focus on the delivery of several new solutions for its diverse customer base. In October, ICAP launched its Swap Execution Facility ("SEF") which is now the market leading venue for trading interest rate derivatives. In November, EBS Direct, ICAP's relationship-based disclosed liquidity service, moved from its pilot phase to commercial launch. Average daily volume has grown from $549 million in November to $2 billion in January. In December, TriOptima resumed compressions at LCH and has since eliminated $41 trillion in gross notional outstanding.

Reduced activity by investment banks as well as the initially disruptive consequence of the new SEF regulatory environment impacted the performance of Global Broking. In Electronic Markets, the performance of BrokerTec, particularly in US Treasuries, was robust as the US Federal Reserve started to taper its quantitative easing programme. Trading volumes in major G7 pairs remained depressed on EBS Market, however, there was record activity levels in Emerging Markets and NDF pairs in January.

The Post Trade Risk and Information business benefitted from increased demand for TriOptima's subscription based portfolio reconciliation service, triResolve, which now has over 800 customers. Traiana continues to expand the breadth of its offering and customer base. While Reset's performance was held back by low interest rate volatility during the period, there has been a recent substantial improvement in activity.

As a result of the challenging market conditions, Group revenue for the third quarter to 31 December 2013 was 6% lower than the same period last year and 5% lower on a constant currency basis. The ongoing cost savings programme remains on track. Management's expectations for PBT1 for the full year remain unchanged, on a constant currency basis. There are, however, a number of external factors that could affect performance in the final quarter in Global Broking. These include continued bank deleveraging as well as the potential impact on financial markets of the SEF made-available-to-trade determinations mandating the execution of certain interest rate swaps on SEF from 15 February.

Michael Spencer, Group Chief Executive Officer, said: "Trading activity across many markets was down in the third quarter, compared to the prior year, with a slower December than we anticipated. Although market conditions remain difficult, we saw a modest improvement in activity in January as the on-going debate about the Federal Reserve quantitative easing programme continued.

"Innovation is vital for our success and our strong cash generation allows us to continue to invest in our future growth. The launch of the ICAP SEF was a very important project. We have had tremendous feedback from customers to our SEF and I am pleased that it is the market leader in interest rate swaps. We are also seeing the tangible benefits of our investments in post trade, as the regulatory push for risk mitigation drives demand for our solutions."

Investors & Analysts Conference Call:

 

This will be hosted by Michael Spencer at 09:00am on Wednesday 5 February 2014:

Dial in number: +44 (0)20 3003 2666Access Code: ICAP14A recording of this call will be available at www.icap.com

 

For further information, please contact:

 

Investors:Alex DeeHead of Investor RelationsTel: +44 (0) 20 7050 7123

Media:Serra BallsActing Head of Corporate CommunicationsTel: +44 (0) 7050 7124

Neil Bennett / Rebecca MitchellMaitlandTel: +44 (0) 20 7379 5151

Notes:

1 Profit before tax before acquisition and disposal costs and exceptional items

The exchange rates at 31 January 2014 were $1.64/£ and €1.22/£.

On the basis rates remain unchanged, the average exchange rate to 31 March 2014 would be $1.59/£ (FY2012/13 $1.58/£) and €1.19/£ (FY2012/13 €1.22/£), the transactional and translation impact on FY2013/14 operating profit would be a reduction of £6m.

For FY2014/15 we are currently hedged 22% of our €/£ and 17% of our £/$ forecast transactional exposures. If average exchange rates for £/$ and £/€ remain at $1.59/£ and €1.19/€, each 1 cent movement in US dollar and euro average exchange rates will impact full-year group profits by approximately £0.8m and £0.9m respectively.

 

About ICAP:ICAP is a leading markets operator and provider of post trade risk mitigation and information services. The Group matches buyers and sellers in the wholesale markets in interest rates, credit, commodities, FX, emerging markets and equity derivatives through voice and electronic networks. Through our post trade risk and information services we help our customers manage and mitigate risks in their portfolios. For more information go to www.icap.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBIGDDUSGBGSS
Date   Source Headline
6th Dec 20125:47 pmRNSHolding(s) in Company
3rd Dec 201212:00 pmRNSTotal Voting Rights
14th Nov 20127:00 amRNSHalf Yearly Report
1st Nov 20122:30 pmRNSTotal Voting Rights
31st Oct 20126:03 pmRNSICAP launches ISDX - Replacement
31st Oct 201210:00 amRNSICAP launches ISDX
19th Oct 201212:43 pmRNSManagement Changes
1st Oct 20122:00 pmRNSTotal Voting Rights
27th Sep 20127:00 amRNSICAP Shipping announces acquisition
26th Sep 20127:00 amRNSTrading Statement
3rd Sep 20123:28 pmRNSTotal Voting Rights
16th Aug 20121:34 pmRNSICAP to create Global Broking Division
15th Aug 201211:00 amRNSBlocklisting Interim Review
15th Aug 201211:00 amRNSBlocklisting Interim Review
15th Aug 201211:00 amRNSBlocklisting Interim Review
1st Aug 201210:01 amRNSTotal Voting Rights
25th Jul 20127:00 amRNSAnalyst and Investor briefing
18th Jul 20121:15 pmRNSFinal Terms Confirmation
17th Jul 20129:00 amRNSEarly closure of Offer Period
12th Jul 20128:00 amRNSPublication of Final Terms
11th Jul 20126:15 pmRNSPublication of Prospectus - Supplement
11th Jul 20124:35 pmRNSDirector Declaration
11th Jul 20123:04 pmRNSResult of AGM
11th Jul 20129:00 amRNSAnnual Financial Report
11th Jul 20127:00 amRNSInterim Management Statement
4th Jul 20123:01 pmRNSAnnual Information Update
2nd Jul 201211:18 amRNSTotal Voting Rights
26th Jun 20123:00 pmRNSPublication of Prospectus
25th Jun 201210:00 amRNSAnnual Financial Report
21st Jun 201212:37 pmRNSICAP completes PLUS Stock Exchange plc acquisition
21st Jun 201212:00 pmRNSHolding(s) in Company
18th Jun 20121:15 pmRNSAcquisition
18th Jun 20127:00 amRNSTransaction in Own Shares
14th Jun 20124:49 pmRNSDirector/PDMR Shareholding
14th Jun 201212:13 pmRNSFurther re Acquisition of PLUS Stock Exchange plc
8th Jun 20121:00 pmRNSAnnual Financial Report
1st Jun 20128:00 amRNSTotal Voting Rights
1st Jun 20127:00 amRNSStatement in Response to Press Release from GMB
29th May 20124:37 pmRNSDirector/PDMR Shareholding
24th May 20125:08 pmRNSDirector/PDMR Shareholding
24th May 20125:04 pmRNSDirector/PDMR Shareholding
24th May 201210:49 amRNSDirector Declaration
18th May 20124:17 pmRNSAcquisition
17th May 20121:22 pmRNSHolding(s) in Company
16th May 20125:10 pmRNSDirector/PDMR Shareholding
16th May 20127:00 amRNSFinal Results
1st May 201211:15 amRNSTotal Voting Rights
2nd Apr 201210:30 amRNSTotal Voting Rights
30th Mar 20125:27 pmRNSDirector/PDMR Shareholding
28th Mar 20127:00 amRNSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.